Skip to main content

Market Overview

Cramer Shares His Thoughts On Teva, Oxford Industries And More


On CNBC's "Mad Money Lightning Round," Jim Cramer said he wouldn't buy Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He explained that it's a generic drugmaker and those stocks are pretty awful in comparison to Merck & Co., Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE) and Bristol-Myers Squibb Co (NYSE: BMY).

Instead of Oxford Industries Inc (NYSE: OXM), Cramer would rather buy PVH Corp (NYSE: PVH).

Cramer likes Amgen, Inc. (NASDAQ: AMGN) and its new oncological franchise.

He prefers Advanced Micro Devices, Inc. (NASDAQ: AMD) over Intel Corporation (NASDAQ: INTC). He believes AMD will take some market share from Intel with its new chips.

Cramer said the CEO of General Electric Company (NYSE: GE) is doing a fantastic job against tremendous circumstances, but he doesn't see the investment in the stock as a diversification strategy.

Cramer likes SpartanNash Co (NASDAQ: SPTN) a lot. He thinks that something must be going on and he sees the stock as a good one.

He would sell a half of a position in Ingevity Corp (NYSE: NGVT) and let the rest run.


Related Articles (TEVA + GE)

View Comments and Join the Discussion!

Posted-In: CNBC Jim Cramer mad money Lightning RoundMedia